Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats

BMC Musculoskeletal Disorders

Volumn 7, Issue , 2006, Pages

  Åstrand, Jörgen ^a   Harding, Anna Kajsa ^a   Aspenberg, Per ^b   Tägil, Magnus ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLEDRONIC ACID;

ANIMAL TISSUE; ARTICLE; BONE ALLOGRAFT; BONE GRAFT; BONE REMODELING; CONTROLLED STUDY; FEMALE; HISTOLOGY; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; RAT; REVASCULARIZATION; TIBIA;

ANIMALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE REGENERATION; BONE REMODELING; BONE RESORPTION; BONE TRANSPLANTATION; DIFFUSION CHAMBERS, CULTURE; DIPHOSPHONATES; FEMALE; GRAFT SURVIVAL; IMIDAZOLES; MALE; OSTEOCLASTS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 33748153210     PISSN: 14712474     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-7-63     Document Type: Article

References (26)

1. Glimcher MJ, Kenzora JE: The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop 1979:273-312.
2. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME: Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002, 32:94-124.
3. Parks NL, Engh GA: Histology of nine structural bone grafts used in total knee arthroplasty. Clin Orthop 1997:17-23.
4. Little DG, Peat RA, Mcevoy A, Williams PR, Smith EJ, Baldock PA: Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 2003, 18:2016-22.
5. Tägil M, Astrand J, Westman L, Aspenberg P: Alendronate prevents collapse in mechanically loaded osteochondral grafts: a bone chamber study in rats. Acta Orthop Scand 2004, 75:756-61.
6. Kim HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F: Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 2005, 87:550-7.
7. Rogers MJ: From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 2004, 75:451-61.
8. McQuade M, Houghton K: Use of bisphosphonates in a case of perthes disease. Orthop Nurs 2005, 24:393-8.
9. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H: Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 2006, 443:273-9.
10. Agarwala S, Jain D, Joshi VR, Sule A: Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology 2005, 44:352-9.
11. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM: The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg 2005, 87:2155-9.
12. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ: Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001, 44:2032-7.
13. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P: Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000, 71:553-7.
14. Venesmaa PK, Kroger HP, Miettinen HJ, Jurvelin JS, Suomalainen OT, Alhav EM: Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res 2001:2126-31.
15. Smith EJ, McEvoy A, Little DG, Baldock PA, Eisman JA, Gardiner EM: Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis. J Bone Miner Res 2004, 19:1698-705.
16. Tägil M, Aspenberg P, Åstrand J: Systemic zoledronate precoating of a bone graft reduces bone resorption during remodelling. Acta Orthop Scand 2006, 77:23-6.
17. Åstrand J, Aspenberg P: Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 2002, 3:19.
18. Doggrell SA: Zoledronate once-yearly increases bone mineral density - implications for osteoporosis. Expert Opin Pharmacother 2002, 7:1007-9. Review
19. Wang JS, Aspenberg P: Basic fibroblast growth factor enhances bone-graft incorporation: dose and time dependence in rats. J Orthop Res 1996, 14:316-23.
20. Thoren K, Aspenberg P: Increased bone ingrowth distance into lipid-extracted bank bone at 6 weeks. A titanium chamber study in allogeneic and syngeneic rats. Arch Orthop Trauma Surg 1995, 114:167-171.
21. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY: Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005, 90:1294-301.
22. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA: Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004, 350:1189-99.
23. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS: Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004, 18:4105-15.
24. Wedemeyer C, von Knoch F, Pingsmann A, Hilken G, Sprecher C, Saxler G, Henschke F, Loer F, von Knoch M: Stimulation of bone formation by zoledronic acid in particle induced osteolysis. Biomaterials 2005, 17:3719-25.
25. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC: Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 2000, 60:6001-7.
26. Plotkin LI, Aguirre JI, Kousteni S, Manolagas SC, Bellido T: Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem 2005, 280:7317-25.